Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[NMO Spectrum Disorders and Anti AQP4 Antibody].
Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome.
Aging-associated changes in motor axon voltage-gated Na(+) channel function in mice.
Tried-and-True Antibiotic May Block Conversion to MS
Multiple sclerosis and infections.
Inducible Expression of a Truncated Form of Tau in Oligodendrocytes Elicits Gait Abnormalities and a Decrease in Myelin: Implications for Selective CNS Degenerative Diseases.
Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands.
Specific protein profile in cerebrospinal fluid from HIV-1-positive cART-treated patients affected by neurological disorders.
Antiviral therapy of two patients with chromosomally-integrated human herpesvirus-6A presenting with cognitive dysfunction.
Comparative diagnostic accuracy of ganglion cell-inner plexiform and retinal nerve fiber layer thickness measures by cirrus and spectralis optical coherence tomography in relapsing-remitting multiple sclerosis.
Cost-Effectiveness Analysis of OnabotulinumtoxinA (BOTOX(®)) for the Management of Urinary Incontinence in Adults with Neurogenic Detrusor Overactivity: A UK Perspective.
Emerging tumefactive multiple sclerosis after switching therapy from natalizumab to fingolimod.
Vitamin D supplementation in multiple sclerosis patients in 2012: hype or reality as an adjunctive therapy?
Evaluating risks, costs, and benefits of new and emerging therapies to optimize outcomes in multiple sclerosis.
Hypogeusia as a symptom of neuromyelitis optica spectrum disorder.
Role of the Human Endogenous Retrovirus HERV-K18 in Autoimmune Disease Susceptibility: Study in the Spanish Population and Meta-Analysis.
Relation between EDSS and monosymptomatic or polysymptomatic onset in clinical manifestations of multiple sclerosis in Babol, northern Iran.
Pathologic heterogeneity persists in early active multiple sclerosis lesions.
Impaired ambulation and steroid therapy impact negatively on bone health in multiple sclerosis.
Study of curcumin immunomodulatory effects on reactive astrocyte cell function.
Quantitative metabolic profiling of lipid mediators.
Using Observational Analysis of Multiple Sclerosis Relapse to Design Outcomes-Based Contracts for Disease-Modifying Drugs: A Feasibility Assessment.
A new model for primary-progressive multiple sclerosis?
Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study.
IL-12, but not IL-23, induces the expression of IL-7 in microglia and macrophages: Implications for multiple sclerosis.

Pages